← Open Payments lookup

QUESHA FOSTER: Open Payments

NPI 1528631066 · GRIFFIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,312 in 56 payments from 13 companies in 2025. Trend: 2023 $260 · 2024 $451 · 2025 $1,312

Food & beverage: $1,312
CompanyPaymentsAmount
ABBVIE INC.12$237
Celltrion USA Inc.7$229
Takeda Pharmaceuticals U.S.A., Inc.9$184
Gilead Sciences, Inc.1$120
Madrigal Pharmaceuticals5$98
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$96
Janssen Biotech, Inc.4$66
Phathom Pharmaceuticals, Inc.3$65
Lilly USA, LLC3$63
Novo Nordisk Inc2$51

Products named: VEGZELMA, ENTYVIO, Livdelzi, REZDIFFRA, RINVOQ, XIFAXAN, CREON, TREMFYA.

Industry payments across GA — which companies pay providers there.